Therefore, it is possible that in addition to the dystrophin variant, variants of large and medium effects in neurodevelopmental genes are most often observed in the DMD/BMD patients with more severe forms of ASD than in those patients without any NDD, following an oligogenic model [24], although no systematic studies have yet addressed this question among DMD/BMD patients. This evidence concerns the gene DMD and Duchenne muscular dystrophy.